IE920979A1 - Pyridazinone acetic acids - Google Patents
Pyridazinone acetic acidsInfo
- Publication number
- IE920979A1 IE920979A1 IE097992A IE920979A IE920979A1 IE 920979 A1 IE920979 A1 IE 920979A1 IE 097992 A IE097992 A IE 097992A IE 920979 A IE920979 A IE 920979A IE 920979 A1 IE920979 A1 IE 920979A1
- Authority
- IE
- Ireland
- Prior art keywords
- methyl
- compound
- oxo
- dihydro
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67691991A | 1991-03-28 | 1991-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IE920979A1 true IE920979A1 (en) | 1992-10-07 |
Family
ID=24716565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE097992A IE920979A1 (en) | 1991-03-28 | 1992-03-27 | Pyridazinone acetic acids |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0582643A1 (2) |
| JP (1) | JPH06500793A (2) |
| CN (1) | CN1065269A (2) |
| AU (1) | AU658887B2 (2) |
| BR (1) | BR9205810A (2) |
| CA (1) | CA2107104A1 (2) |
| CZ (1) | CZ387092A3 (2) |
| DE (1) | DE9290035U1 (2) |
| FI (1) | FI934222A7 (2) |
| HU (1) | HUT67836A (2) |
| IE (1) | IE920979A1 (2) |
| IL (1) | IL101325A0 (2) |
| MX (1) | MX9201414A (2) |
| NZ (1) | NZ242152A (2) |
| PT (1) | PT100301A (2) |
| TW (1) | TW207998B (2) |
| WO (1) | WO1992017446A2 (2) |
| YU (1) | YU30392A (2) |
| ZA (1) | ZA922238B (2) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2240657T3 (es) * | 2001-02-28 | 2005-10-16 | Pfizer Products Inc. | Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa. |
| SE0100873D0 (sv) * | 2001-03-13 | 2001-03-13 | Astrazeneca Ab | Method of treatment |
| ATE348100T1 (de) | 2001-03-30 | 2007-01-15 | Pfizer Prod Inc | Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren. |
| AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| CN111617072B (zh) * | 2019-02-27 | 2023-06-20 | 苏州凯祥生物科技有限公司 | 一种高尿酸血症药物组合物及用于治疗高尿酸血症的药物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
| FR2647676A1 (fr) * | 1989-06-05 | 1990-12-07 | Union Pharma Scient Appl | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase |
-
1992
- 1992-03-09 CZ CS923870A patent/CZ387092A3/cs unknown
- 1992-03-09 DE DE9290035U patent/DE9290035U1/de not_active Expired - Lifetime
- 1992-03-09 EP EP92910955A patent/EP0582643A1/en not_active Withdrawn
- 1992-03-09 AU AU17796/92A patent/AU658887B2/en not_active Ceased
- 1992-03-09 HU HU9302728A patent/HUT67836A/hu unknown
- 1992-03-09 FI FI934222A patent/FI934222A7/fi not_active Application Discontinuation
- 1992-03-09 BR BR9205810A patent/BR9205810A/pt not_active Application Discontinuation
- 1992-03-09 JP JP4509938A patent/JPH06500793A/ja active Pending
- 1992-03-09 WO PCT/US1992/001603 patent/WO1992017446A2/en not_active Ceased
- 1992-03-09 CA CA002107104A patent/CA2107104A1/en not_active Abandoned
- 1992-03-13 TW TW081101914A patent/TW207998B/zh active
- 1992-03-22 IL IL101325A patent/IL101325A0/xx unknown
- 1992-03-26 PT PT100301A patent/PT100301A/pt not_active Application Discontinuation
- 1992-03-26 YU YU30392A patent/YU30392A/sh unknown
- 1992-03-27 ZA ZA922238A patent/ZA922238B/xx unknown
- 1992-03-27 NZ NZ24215292A patent/NZ242152A/en unknown
- 1992-03-27 CN CN92102224A patent/CN1065269A/zh active Pending
- 1992-03-27 MX MX9201414A patent/MX9201414A/es unknown
- 1992-03-27 IE IE097992A patent/IE920979A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06500793A (ja) | 1994-01-27 |
| CZ387092A3 (en) | 1994-02-16 |
| EP0582643A1 (en) | 1994-02-16 |
| MX9201414A (es) | 1992-10-01 |
| PT100301A (pt) | 1993-06-30 |
| CA2107104A1 (en) | 1992-09-29 |
| TW207998B (2) | 1993-06-21 |
| HUT67836A (en) | 1995-05-29 |
| FI934222L (fi) | 1993-09-27 |
| DE9290035U1 (de) | 1993-11-18 |
| IL101325A0 (en) | 1992-11-15 |
| BR9205810A (pt) | 1994-06-28 |
| WO1992017446A3 (en) | 1992-11-26 |
| YU30392A (sh) | 1994-11-15 |
| AU658887B2 (en) | 1995-05-04 |
| FI934222A0 (fi) | 1993-09-27 |
| CN1065269A (zh) | 1992-10-14 |
| FI934222A7 (fi) | 1993-09-27 |
| HU9302728D0 (en) | 1993-12-28 |
| WO1992017446A2 (en) | 1992-10-15 |
| ZA922238B (en) | 1993-09-27 |
| NZ242152A (en) | 1994-07-26 |
| AU1779692A (en) | 1992-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0222576B1 (en) | Heterocyclic oxophthalazinyl acetic acids | |
| US4353900A (en) | 9-(Arylalkyl or aroylalkyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones | |
| US5268386A (en) | Certain 3,4-dihydro 4-oxospiro [2H-1 benzopyrans] useful for treating hyperuricemia | |
| AU611610B2 (en) | Pyridazinone derivatives | |
| HU215450B (hu) | Eljárás 2,4-dioxo-tiazolidin-származékok előállítására | |
| EP0436307B1 (en) | Substituted oxophthalazinyl acetic acids and analogs thereof | |
| US5338855A (en) | Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses | |
| FR2647676A1 (fr) | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase | |
| EP0266102B1 (en) | Quinoxalinone derivatives | |
| AU658887B2 (en) | Pyridazinone acetic acids as aldose reductase inhibitors | |
| DE69625795T2 (de) | Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven Eigenschaften, Verfahren zu deren Herstellung und pharmazeutischen Zusammenstellungen, die sie enthalten | |
| EP0553130B1 (en) | Pyrrolidine dione derivatives | |
| EP0136143B1 (en) | Spiro-succinimides for treatment of diabetes complications | |
| US4457939A (en) | Aldose reductase inhibiting 5-(2-alkoxy-3-substituted phenyl)hydantoins | |
| KR860001507B1 (ko) | 5-(치환된 페닐) 히단토인의 제조방법 | |
| US4766141A (en) | Spiro-succinimides for treatment of diabetes complications | |
| EP0112620B1 (en) | 5-(substituted phenyl) hydantoins | |
| EP0171213B1 (en) | Spiro-imidazolones for treatment of diabetic complications | |
| DE19711617A1 (de) | Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| CA1188318A (en) | N-(substituted-naphthoyl)glycine derivatives | |
| EP0568540A1 (en) | 2,4-DIOXO-PYRIDO 2,3-d]PYRIMIDINE-3-ACETIC ACIDS AND ESTERS AND SALTS THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Application withdrawn section 33(1) |